Publications by authors named "S-P Issa"

Claim this Profile
U
Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib.
Fadi G Haddad, Cedric Nasnas, Koji Sasaki, Shilpa Paul, Ghayas C Issa

Clin Lymphoma Myeloma Leuk· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study.
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, Jean-Pierre J Issa, Gail J Roboz

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors.
Elias J Jabbour, Koji Sasaki, Fadi G Haddad, Ghayas C Issa, Guillermo Garcia-Manero, Issa F Khouri

Am J Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism.
Athena Cavounidis, Sumeet Pandey, Melania Capitani, Matthias Friedrich, Amy Cross, Fadi Issa

Mucosal Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.
C G Roehrborn, M M Issa, R C Bruskewitz, M J Naslund, J E Oesterling

Urology· March 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis